Last edition
News about "Piramal Pharma Limited"
Piramal Pharma Completes US FDA Inspection at Lexington Facility
Piramal Pharma receives US FDA EIR with VAI status for its Lexington facility, marking successful closure of inspection and regulatory compliance.
Piramal Pharma Limited | 13/04/2026 | By News Bureau | 195
Piramal Pharma gets listed in BSE and NSE
The listing is in line with the objective to transform the group from a multi-sector conglomerate into two separate sector-focused listed entities
Piramal Pharma Limited | 20/10/2022 | By Sudeep Soparkar | 961
Yapan Bio adds process development facility
Expands capacity and capabilities in large molecule therapeutics
Piramal Pharma Limited | 19/10/2022 | By Sudeep Soparkar | 770
Piramal Pharma appoints Vibha Paul Rishi to its Board of Directors
Rishi is a marketing professional and has held global leadership positions across branding, strategy, innovation and human capital
Piramal Pharma Limited | 30/09/2022 | By Sudeep Soparkar | 1067
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy